<bill session="117" type="s" number="4215" updated="2023-08-07T16:15:22Z">
  <state datetime="2022-05-12">REFERRED</state>
  <status>
    <introduced datetime="2022-05-12"/>
  </status>
  <introduced datetime="2022-05-12"/>
  <titles>
    <title type="display">Give Kids a Chance Act of 2022</title>
    <title type="short" as="introduced">Give Kids a Chance Act of 2022</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to establish additional authorities of the Food and Drug Administration regarding the conduct of pediatric investigations of molecularly targeted drugs to treat cancer, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="R000595"/>
  <cosponsors>
    <cosponsor bioguide_id="B001267" joined="2022-05-12"/>
  </cosponsors>
  <actions>
    <action datetime="2022-05-12">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-05-12" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="5416" relation="unknown"/>
    <bill session="117" type="h" number="6972" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2023-08-07T16:09:00Z" status="Introduced in Senate">Give Kids a Chance Act of 2022

This bill authorizes the Food and Drug Administration (FDA) to take various actions regarding pediatric cancer treatments, such as requiring pediatric cancer trials involving a combination of drugs when an applicant seeks market approval for a new drug (or biological product).</summary>
</bill>
